This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Multiple Endocrine Neoplasia
Information about Multiple Endocrine Neoplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Multiple Endocrine Neoplasia
Most recent studies have shown that Multiple Endocrine Neoplasia shares some biological mechanisms with adenoma, adrenal-gland-neoplasms, carcinoma, endocrine-gland-neoplasms, hyperplasia, malignant-neoplasm-of-thyroid, malignant-neoplasms, malignant-paraganglionic-neoplasm, medullary-carcinoma-of-thyroid, multiple-endocrine-neoplasia-type-1, multiple-endocrine-neoplasia-type-2a, multiple-endocrine-neoplasia-type-2b, neoplasm-metastasis, neoplasms, pancreatic-neoplasm, parathyroid-neoplasms, pheochromocytoma, pituitary-diseases, thyroid-neoplasm.
Among the many pathways, these few ones have gauged particular interests from scientists studying Multiple Endocrine Neoplasia, and have been seen in publications frequently: Acid Secretion, Cell Cycle, Cell Growth, Cell Proliferation, Endosperm Development, Enucleation, Excretion, Fertilization, Hormone Secretion, Innervation, Localization, Methylation, Oncogenesis, Pathogenesis, Pigmentation, Platelet Aggregation, Secretion, Seed Development, Translation, Transport
Quite a number of genes have been found to play important roles in Multiple Endocrine Neoplasia, such as CALCA, CDKN1B, ELL, GAST, GDNF, INS, MEA1, MEN1, MT1A, NTRK1, POMC, PPY, PRL, PTH, PTRH1, RET, SST, VHL. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.